rheumatologyadvisor16h
Tirzepatide Bests Semaglutide in Head-to-Head Weight Loss Trial
The most common adverse events reported with both treatments were mild to moderate gastrointestinal-related side effects.
GlobalData on MSN2d
BioAge halts ongoing Phase II trial of obesity drug due to liver concerns
In the trail, 11 participants in the azelaprag group exhibited transaminase elevations without significant symptoms.
BMJ6d
Tirzepatide: Obesity injection will get phased rollout to avoid overwhelming GPs
GP leaders have warned that the rollout of the weight loss drug tirzepatide (Mounjaro, Eli Lilly) will still have ...
Just Two Months After IPO, BioAge Labs Stops Eli Lilly-Collaborated Obesity Trial On Safety Concerns
BioAge Labs halts STRIDES Phase 2 trial of azelaprag after liver enzyme elevations, plans further analysis with updates ...
Medpage Today on MSN7d
Tirzepatide Tops Semaglutide for Weight Loss in Head-to-Head Trial, Eli Lilly Says
Those treated with tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist, lost on ...
National Institute for Health and Care Excellence6d
Tirzepatide - a new chapter in obesity treatment
Tirzepatide has been shown in clinical trials to be more effective than diet and exercise support alone, and when compared ...
FiercePharma7d
For first phase of Mounjaro's obesity rollout in England, only a limited number of patients will have access
Following its endorsement of Eli Lilly’s obesity medicine tirzepatide, England’s National Institute for Health and Care ...
The American Journal of Managed Care26d
For Obesity and HFpEF, Tirzepatide Cuts Risk of CV Death or Worsening HF by 38%
Tirzepatide reduced cardiovascular death or heart failure worsening by 38% in patients with obesity and HFpEF, compared to placebo. The trial showed significant weight loss and improved insulin ...
The New England Journal of Medicine29d
Tirzepatide for Obesity Treatment and Diabetes Prevention
Obesity is chronic disease and causal precursor to myriad other conditions, including type 2 diabetes. In an earlier analysis of the SURMOUNT-1 trial, tirzepatide was shown to provide substantial ...
Medscape26d
Tirzepatide Reduces Heart Failure Events in HFpEF With Obesity
Tirzepatide also had meaningful and significant effects on health status, exercise tolerance, and systemic inflammation. "SUMMIT is the first trial in patients with HFpEF and obesity that had ...
Science News5d
How the weight loss drug tirzepatide is also helping heart failure patients
Data continue to show that tirzepatide, called Mounjaro for type 2 diabetes and Zepbound for weight loss, is safe and effective, but side effects remain.